Table 1.

Case reports of cranial nerve-related intracranial IPTs

Authors and year	Patient age (years), sex	Involved cranial nerves	Presenting symptoms and signs	Treatment	Result	Follow-up (months)
Le Marc'hadour et al (1985)	40, M	rt III or rt V	rt blindness, HA	1. Partial removal 2. Steroid	1. III paralysis 2. No change in tumour and symptoms	24
Yanagihara et al (1991)	41, M	rt VII	rt facial paralysis	1. Steroid 2. Total removal	1. Remission of symptoms, recurrence after the treatment 2. VII paralysis, no recurrence	24
Kodsi et al (1993)	40, M	lt V	lt optic neuropathy	1. Biopsy 2. Steroid	1. No deficit 2. Partial reduction of the tumour, remission of the symptom	17
McKinney et al (2006)	50, M	lt II, V, IX	lt blindness, ptosis, facial numbness, dysphonia, dysphagia, hoarseness	1. Biopsy 2. Steroid	1. No deficit 2. Remission of tumour and symptoms, recurrence by the reduced dose	6
Jung et al (2006)	52, M	lt V	lt facial numbness, HA	1. Total removal	1. V paralysis (facial numbness), no recurrence	18
Seol et al (2009)	24, F	lt V	lt facial numbness, HA	1. Biopsy 2. Steroid	1. No deficit 2. Remission of tumour and symptoms	8
Present study	63, M	bil III	bil optic neuropathy	1. Biopsy 2. Steroid	1. III paralysis 2. Remission of tumour, no change in symptoms	9

HA, headache.